Immune checkpoint inhibitors for patients with gene-rearranged non-small cell lung cancer

被引：1
|
作者：
Uehara, Yuji [1 ,2 ]
Hakozaki, Taiki [1 ,3 ,4 ]
机构：
[1] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, Tokyo, Japan
[2] Tokyo Med & Dent Univ, Ctr Innovat Canc Treatment, Grad Sch Med & Dent Sci, Dept Precis Canc Med, Tokyo, Japan
[3] Waseda Univ, Fac Sci & Engn, Grad Sch Adv Sci & Engn, Tokyo, Japan
[4] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Thorac Oncol & Resp Med, 3-18-22 Honkomagome, Bunkyo, Tokyo, Japan
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2023年 / 12卷 / 01期
关键词：
Immune checkpoint inhibitor (ICI); non-small cell lung cancer (NSCLC); gene rearrangement; biomarker; prognosis; OUTCOMES; IMMUNOTHERAPY; MUTATIONS; EFFICACY; BLOCKADE; NSCLC;
D O I：
10.21037/tlcr-22-872
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：6 / 10
页数：5
相关论文
共 50 条
  • [21] Safety of current immune checkpoint inhibitors in non-small cell lung cancer
    Abdayem, Pamela
    Planchard, David
    EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) : 651 - 667
  • [22] Achievements and futures of immune checkpoint inhibitors in non-small cell lung cancer
    Zhenbin Qiu
    Zihao Chen
    Chao Zhang
    Wenzhao Zhong
    Experimental Hematology & Oncology, 8
  • [23] Efficacy and safety of immune checkpoint inhibitors in non-small cell lung cancer
    Wang, Shuai
    Hao, Jiatao
    Wang, Hao
    Fang, Yong
    Tan, Lijie
    ONCOIMMUNOLOGY, 2018, 7 (08):
  • [24] Immune checkpoint inhibitors in therapy of non-small cell lung cancer (a review)
    Kolesnik, O. P.
    Mykhailychenko, V. V.
    ZAPOROZHYE MEDICAL JOURNAL, 2021, 23 (03) : 418 - 425
  • [25] Incidence of Cardiotoxicity in Patients Treated for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors
    Carpenter, I. N.
    Brice, K. B.
    Walker, D.
    Dumais, K.
    Alvarez, A. M.
    Cohen, N. S.
    Raez, L. E.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S629 - S629
  • [26] Infectious Complications in Patients With Non-small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
    Guo, Matthew Z.
    Balaji, Aanika
    Murray, Joseph C.
    Reuss, Joshua E.
    Steinke, Seema Mehta
    Bennett, Kathleen
    Naidoo, Jarushka
    CLINICAL LUNG CANCER, 2023, 24 (07) : 613 - 620
  • [27] Impact of Gender on Response to Immune Checkpoint Inhibitors in Patients with Non-small Cell Lung Cancer
    Lee, J. C.
    Choi, M. G.
    Ji, W.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S357 - S358
  • [28] Re-administration of immune checkpoint inhibitors for patients with non-small cell lung cancer
    Hakozaki, Taiki
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022,
  • [29] Immune checkpoint inhibitors for every patient with non-small cell lung cancer? Update on immunotherapy in patients with lung cancer
    Vansteenkiste, Johan F.
    ESMO OPEN, 2018, 3 (06)
  • [30] Efficacy and tolerance of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung disease
    Kobayashi, Haruki
    RESPIROLOGY, 2020, 25 (08) : 892 - 893
12345